Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Terri Allen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Chemicals & Drugs
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
54
Cooper, Mark
26
Jerums, George
19
Jandeleit-Dahm, Karin
14
Gilbert, Richard
14
Cao, Zemin
11
Lassila, Markus
9
Calkin, Anna
8
Candido, Riccardo
8
O'Brien, RC
8
Tsalamandris, Con
6
Rumble, Jon
6
Forbes, Josephine
5
Panagiotopoulos, Sianna
5
Bach, Leon
5
Burrell, Louise
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Terri Allen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2007: Calkin Anna C; Allen Terri J; Lassila Markus; Tikellis Christos; Jandeleit-Dahm Karin A; Thomas Merlin C
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.
Atherosclerosis 2007;195(1):17-22.
-
2007: Lewis Paul; Stefanovic Nada; Pete Josefa; Calkin Anna C; Giunti Sara; Thallas-Bonke Vicki; Jandeleit-Dahm Karin A; Allen Terri J; Kola Ismail; Cooper Mark E; de Haan Judy B
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Circulation 2007;115(16):2178-87.
-
2007: Calkin A C; Jandeleit-Dahm K A; Sebekova E; Allen T J; Mizrahi J; Cooper M E; Tikellis C
PPARs and diabetes-associated atherosclerosis.
Current pharmaceutical design 2007;13(26):2736-41.
-
2006: Calkin Anna C; Giunti Sara; Jandeleit-Dahm Karin A; Allen Terri J; Cooper Mark E; Thomas Merlin C
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(9):2399-405.
-
2006: Calkin A C; Cooper M E; Jandeleit-Dahm K A; Allen T J
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.
Diabetologia 2006;49(4):766-74.
-
2006: Calkin Anna C; Allen Terri J
Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(1):15-40.
-
2005: Allen T J; Jandeleit-Dahm K A
Preventing atherosclerosis with angiotensin-converting enzyme inhibitors: emphasis on diabetic atherosclerosis.
Current drug targets. Cardiovascular & haematological disorders 2005;5(6):503-12.
-
2005: Dilley Rodney J; Farrelly Caroline A; Allen Terri J; Jandeleit-Dahm Karin; Cooper Mark E; Morahan Grant; Little Peter J
Diabetes induces Na/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries.
Diabetes research and clinical practice 2005;70(3):201-8.
-
2005: Jandeleit-Dahm Karin; Lassila Markus; Davis Belinda J; Candido Riccardo; Johnston Colin I; Allen Terri J; Burrell Louise M; Cooper Mark E
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
Journal of hypertension 2005;23(11):2071-82.
-
2005: Calkin Anna C; Forbes Josephine M; Smith Craig M; Lassila Markus; Cooper Mark E; Jandeleit-Dahm Karin A; Allen Terri J
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1903-9.
-
2005: Jandeleit-Dahm Karin A; Lassila Markus; Allen Terri J
Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies.
Annals of the New York Academy of Sciences 2005;1043():759-66.
-
2005: Lassila Markus; Jandeleit-Dahm Karin; Seah Kwee K; Smith Craig M; Calkin Anna C; Allen Terri J; Cooper Mark E
Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Journal of the American Society of Nephrology : JASN 2005;16(2):363-73.
-
2004: Jerums G; Allen T J; Campbell D J; Cooper M E; Gilbert R E; Hammond J J; O'Brien R C; Raffaele J; Tsalamandris C;
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(11):1192-9.
-
2004: Ma Guorong; Allen Terri J; Cooper Mark E; Cao Zemin
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
Kidney international 2004;66(3):1090-8.
-
2004: Lassila Markus; Seah Kwee K; Allen Terri J; Thallas Vicki; Thomas Merlin C; Candido Riccardo; Burns Wendy C; Forbes Josephine M; Calkin Anna C; Cooper Mark E; Jandeleit-Dahm Karin A M
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
Journal of the American Society of Nephrology : JASN 2004;15(8):2125-38.
-
2004: Forbes Josephine M; Yee Louis Teo Loon; Thallas Vicki; Lassila Markus; Candido Riccardo; Jandeleit-Dahm Karin A; Thomas Merlin C; Burns Wendy C; Deemer Elizabeth K; Thorpe Susan R; Cooper Mark E; Allen Terri J
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
Diabetes 2004;53(7):1813-23.
-
2004: Lassila Markus; Allen Terri J; Cao Zemin; Thallas Vicki; Jandeleit-Dahm Karin A; Candido Riccardo; Cooper Mark E
Imatinib attenuates diabetes-associated atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(5):935-42.
-
2004: Candido Riccardo; Allen Terri J; Lassila Markus; Cao Zemin; Thallas Vicki; Cooper Mark E; Jandeleit-Dahm Karin A
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Circulation 2004;109(12):1536-42.
-
2004: Davis B J; Forbes J M; Thomas M C; Jerums G; Burns W C; Kawachi H; Allen T J; Cooper M E
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
Diabetologia 2004;47(1):89-97.
-
2003: Davis B J; Johnston C I; Burrell L M; Burns W C; Kubota E; Cao Z; Cooper M E; Allen T J
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
Diabetologia 2003;46(7):961-71.
-
2003: Lassila Markus; Davis Belinda J; Allen Terri J; Burrell Louise M; Cooper Mark E; Cao Zemin
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Clinical science (London, England : 1979) 2003;104(4):341-7.
-
2003: Little Peter J; Allen Terri J; Hashimura Kazuhiko; Nigro Julie; Farrelly Caroline A; Dilley Rodney J
High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1.
Diabetes research and clinical practice 2003;59(2):93-101.
-
2003: Davis Belinda J; Cao Zemin; de Gasparo Marc; Kawachi Hiroshi; Cooper Mark E; Allen Terri J
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
Journal of hypertension 2003;21(1):209-16.
-
2002: Candido Riccardo; Allen Terri J
Haemodynamics in microvascular complications in type 1 diabetes.
Diabetes/metabolism research and reviews 2002;18(4):286-304.
-
2002: Candido Riccardo; Jandeleit-Dahm Karin A; Cao Zemin; Nesteroff Stefan P; Burns Wendy C; Twigg Stephen M; Dilley Rodney J; Cooper Mark E; Allen Terri J
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
Circulation 2002;106(2):246-53.
-
2002: Forbes Josephine M; Bonnet Fabrice; Russo Leileata M; Burns Wendy C; Cao Zemin; Candido Riccardo; Kawachi Hiroshi; Allen Terri J; Cooper Mark E; Jerums George; Osicka Tanya M
Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.
Journal of hypertension 2002;20(5):985-92.
-
2002: Houlihan Christine A; Allen Terri J; Baxter Amynta L; Panangiotopoulos Sianna; Casley David J; Cooper Mark E; Jerums George
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
Diabetes care 2002;25(4):663-71.
-
2002: Tikkanen Ilkka; Tikkanen Tuula; Cao Zemin; Allen Terri J; Davis Belinda J; Lassila Markus; Casley David; Johnston Colin I; Burrell Louise M; Cooper Mark E
Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Journal of hypertension 2002;20(4):707-14.
-
2001: Mifsud S A; Allen T J; Bertram J F; Hulthen U L; Kelly D J; Cooper M E; Wilkinson-Berka J L; Gilbert R E
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
Diabetologia 2001;44(7):878-82.
-
2001: Bonnet F; Cooper M E; Kawachi H; Allen T J; Boner G; Cao Z
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
Diabetologia 2001;44(7):874-7.
-
2001: Cao Z; Bonnet F; Davis B; Allen T J; Cooper M E
Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
Clinical science (London, England : 1979) 2001;100(6):591-9.
-
2001: Jerums G; Allen T J; Campbell D J; Cooper M E; Gilbert R E; Hammond J J; Raffaele J; Tsalamandris C
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(5):890-9.
-
2001: Forbes J M; Jandeleit-Dahm K; Allen T J; Hewitson T D; Becker G J; Jones C L
Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure.
Experimental nephrology 2001;9(5):309-16.
-
2000: Jandeleit-Dahm K; Hannan K M; Farrelly C A; Allen T J; Rumble J R; Gilbert R E; Cooper M E; Little P J
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.
Circulation research 2000;87(12):1133-40.
-
2000: Gilbert R E; Rumble J R; Cao Z; Cox A J; van Eeden P; Allen T J; Kelly D J; Cooper M E
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
Circulation research 2000;86(2):158-65.
-
2000: Jandeleit-Dahm K; Allen T J; Youssef S; Gilbert R E; Cooper M E
Is there a role for endothelin antagonists in diabetic renal disease?
Diabetes, obesity & metabolism 2000;2(1):15-24.
-
1998: Cooper M E; Cao Z; Rumble J R; Jandeleit K; Allen T J; Gilbert R E
Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.
Metabolism: clinical and experimental 1998;47(12 Suppl 1):24-7.
-
1998: Tikkanen T; Tikkanen I; Rockell M D; Allen T J; Johnston C I; Cooper M E; Burrell L M
Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Hypertension 1998;32(4):778-85.
-
1998: Kelly D J; Wilkinson-Berka J L; Allen T J; Cooper M E; Skinner S L
A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).
Kidney international 1998;54(2):343-52.
-
1998: Cao Z; Hulthén U L; Allen T J; Cooper M E
Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
Journal of hypertension 1998;16(6):793-9.
-
1998: Gilbert R E; Cox A; Wu L L; Allen T J; Hulthen U L; Jerums G; Cooper M E
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
Diabetes 1998;47(3):414-22.
-
1998: Gilbert R E; Tsalamandris C; Allen T J; Colville D; Jerums G
Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus.
Journal of the American Society of Nephrology : JASN 1998;9(1):85-9.
-
1997: Jerums G; Panagiotopoulos S; Tsalamandris C; Allen T J; Gilbert R E; Comper W D
Why is proteinuria such an important risk factor for progression in clinical trials?
Kidney international. Supplement 1997;63():S87-92.
-
1997: Allen T J; Cao Z; Youssef S; Hulthen U L; Cooper M E
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Diabetes 1997;46(10):1612-8.
-
1997: Allen T J; Waldron M J; Casley D; Jerums G; Cooper M E
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
Diabetes 1997;46(1):19-24.
-
1996: Allen T J; Cooper M E; Gilbert R E; Winikoff J; Skinni S L; Jerums G
Serum total renin is increased before microalbuminuria in diabetes.
Kidney international 1996;50(3):902-7.
-
1995: Allen T J; Hulthen U L; Rumble J R; Jasik M; Cooper M E
Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
Journal of diabetes and its complications 1995;9(4):318-22.
-
1995: Jerums G; Allen T J; Gilbert R E; Hammond J; Cooper M E; Campbell D J; Raffaele J
Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
Journal of diabetes and its complications 1995;9(4):308-14.
-
1994: Komers R; Allen T J; Cooper M E
Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Diabetes 1994;43(10):1190-7.
-
1994: Tsalamandris C; Allen T J; Gilbert R E; Sinha A; Panagiotopoulos S; Cooper M E; Jerums G
Progressive decline in renal function in diabetic patients with and without albuminuria.
Diabetes 1994;43(5):649-55.
-
1994: Bach L A; Cooper M E; Vranes D; Allen T J; Rumble J; Jerums G
Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
Diabetes research (Edinburgh, Scotland) 1994;27(1):27-38.
-
1993: Gilbert R E; Tsalamandris C; Bach L A; Panagiotopoulos S; O'Brien R C; Allen T J; Goodall I; Young V; Seeman E; Murray R M
Long-term glycemic control and the rate of progression of early diabetic kidney disease.
Kidney international 1993;44(4):855-9.
-
1993: Jerums G; Allen T J; Tsalamandris C; Akdeniz A; Sinha A; Gilbert R; Cooper M E
Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients.
Diabetologia 1993;36(10):1037-44.
-
1993: Cooper M E; Vranes D; Vranes D A; Allen T J; Panagiotopoulos S; Komers R; Jerums G
The effects of dietary cholesterol on experimental diabetic nephropathy.
Diabetes research (Edinburgh, Scotland) 1993;22(4):159-69.
-
1992: Jerums G; Allen T J; Tsalamandris C; Cooper M E
Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group.
Kidney international 1992;41(4):904-11.
-
1992: Cooper M E; Rumble J R; Allen T J; O'Brien R C; Jerums G; Doyle A E
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Kidney international 1992;41(4):898-903.
-
1991: Bach L A; Stevenson J L; Allen T J; Jerums G; Herington A C
Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats.
The Journal of endocrinology 1991;129(1):5-10.
-
1990: Cooper M E; Allen T J; O'Brien R C; Papazoglou D; Clarke B E; Jerums G; Doyle A E
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Diabetes 1990;39(12):1575-9.
-
1990: Allen T J; Cooper M E; O'Brien R C; Bach L A; Jackson B; Jerums G
Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.
Diabetes 1990;39(10):1182-90.
-
1990: Cooper M E; Vranes D A; Panagiotopoulos S; Allen T J; Goodall I; Jerums G
Hyperlipidaemia increases albuminuria in hypertensive and normotensive rats.
Clinical and experimental pharmacology & physiology 1990;17(3):225-8.
-
1989: O'Brien R C; Cooper M E; Allen T J; Jerums G
Ramipril reduces albuminuria in diabetic rats fed a high protein diet.
Clinical and experimental pharmacology & physiology 1989;16(8):675-80.
-
1989: Cooper M E; Allen T J; Macmillan P A; Clarke B E; Jerums G; Doyle A E
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
Diabetologia 1989;32(5):326-8.
-
1988: Cooper M E; Allen T J; O'Brien R C; Macmillan P A; Clarke B; Jerums G; Doyle A E
Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.
Journal of hypertension 1988;6(12):1009-16.
-
1988: Jackson B; Franze L; Allen T J; O'Brien R; Cooper M; Hodsman G P; Jerums G
Effect of glycaemic control on glomerular filtration rate in the streptozotocin diabetic rat.
Clinical and experimental pharmacology & physiology 1988;15(4):361-5.
-
1988: O'Brien R C; Allen T J; Cooper M E; Bach L; Jerums G
Glomerular filtration rate in early experimental diabetes.
The Journal of diabetic complications 1988;2(1):8-11.
-
1988: Cooper M E; Allen T J; Macmillan P; Bach L; Jerums G; Doyle A E
Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.
American journal of hypertension 1988;1(1):5-10.
Sign-in to see more
